Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion type Assertion NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_head.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion description "[Estimation of CT7, also referred to as MAGE-C1, immunoreactivity is of limited prognostic usefulness in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_provenance.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion evidence source_evidence_literature NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_provenance.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion SIO_000772 17607369 NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_provenance.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion wasDerivedFrom lhgdn-20090331 NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_provenance.
- NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_assertion wasGeneratedBy ECO_0000203 NP172757.RAinm0unJl1uT_KK3opwsD9UxkFSxI8G5m3lR8uIqcqSU130_provenance.